Drug Interaction Charts
 
Please use this area to search on potential interactions between a wide range of drug treatment combinations.

NEW
We have simplified the way in which you can view our Interactions Charts – all the classes of HIV drugs can now be viewed on one chart.

Select one of the following options that suits your particular Drug Interactions requirements:

  1. Click here to check for interactions with HIV drugs and other drugs.
  2. Click here for printable charts.
DRUG INTERACTION NEWS
New format interaction charts
Added: Tuesday 6th October 2009
The format of the interaction charts has been changed to make searching for interactions easier and to distinguish between those interactions for which data exists (“referenced interactions”) and those which are predicted based on routes of metabolism and elimination (“theoretical interactions”). more...

LATEST NEWS
Drug Interactions - Maraviroc and raltegravir.  
Case Reports - Quetiapine and atazanavir/ritonavir.  
Drug Interactions - Tipranavir/ritonavir and efavirenz.  
Drug Interactions - Rifabutin and lopinavir/ritonavir.  
Drug Interactions - Tipranavir/ritonavir and statins.  
Drug Interactions - Raltegravir/etravirine clinical trial data.  

Click here for previous news items
In HIV therapy today, patients take more than one antiretroviral medication at a time and possibly other drugs to treat co-existing conditions. While some drug combinations do not interact significantly in vivo, other drug combinations can affect the patient's safety and the effectiveness of treatment. For this reason some drug combinations should not be given at all, while other drugs may be used together with caution, possibly requiring adjustments to dosage or time of administration.

Alterations in drug concentrations of a co-medication can commonly occur with administration of antiretroviral drugs. The charts on this site are a guide to interactions that may occur between different anti-HIV drugs and other medications that the HIV+ patient may be prescribed.

Charts for NRTIs and Entry/Integrase Inhibitors

These charts are less extensive than the PI and NNRTI charts and have been compiled from the Summary of Product Characteristics, Prescribing Information, meeting abstracts and full papers. With a few exceptions, only drugs cited in these sources are listed. If a drug is not present, there are no data available.


Information supplied and monitored by

THE LIVERPOOL HIV PHARMACOLOGY GROUP

Liverpool Univesity

This website is provided for information only. It is not intended to replace a consultation with an appropriately qualified health professional. We aim to ensure that the information published on this website is accurate and consistent with current knowledge and practice. However, medical knowledge and practice is constantly evolving and individual cases may require specific advice that cannot be addressed through this website. The University of Liverpool, eMedFusion and their servants or agents shall not be responsible or in any way liable for the continued currency of the information or for any errors, omissions or inaccuracies in this publication whether arising from negligence or otherwise howsoever or for any consequences arising therefrom. The University of Liverpool and eMedFusion expressly exclude liability for errors, omissions or inaccuracies to the fullest extent permitted by law.

top of the page

Last reviewed: 22 December 2009

Copyright © 1999- The University of Liverpool. All rights reserved. Site developed and maintained by The University of Liverpool and eMedFusion